Diclofenac Transdermal Patch and Opipramol: Interaction Details

Brand names
Diclofenac Transdermal Patch
Flector PatchLicart Topical SystemZorvolex +12 more
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page

A close look at the Diclofenac Transdermal Patch and Opipramol interaction:

Share

Share this interaction

Opipramol

We don't have a drug information page for Opipramol yet. Have a question about Opipramol? Ask a pharmacist, free →

Diclofenac Transdermal Patch

Brand names
  • Flector Patch
  • Licart Topical System
  • Zorvolex
  • Pennsaid
  • Licart
  • Aleve Arthritis Pain
  • Lofena
  • Xiclo
  • Flector
  • Voltaren
  • Cataflam
  • Zipsor
  • Cambia
  • diclofenac epolamine
  • Diclox Patch 30CT

What Happens When You Take Diclofenac Transdermal Patch With Opipramol

What can happen when they are taken together (rated Major)

An increased risk of bleeding

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Giving together with calls for caution, since the combination may raise the risk of bleeding, intracranial included, during the first 30 days of .1 Patients receiving both NSAIDs and tricyclic antidepressants at the same time should be monitored for signs of increased bleeding.

The Diclofenac Transdermal Patch and Opipramol Interaction, Explained

Opipramol is a tricyclic medicine used for anxiety, and the diclofenac patch (like Flector or Licart) is an anti-inflammatory pain reliever you put on your skin. Using them together has been linked to a higher chance of bleeding, and in rare cases this can include serious bleeding in the brain. Doctors don't know exactly why this happens. Patches send less medicine into the blood than pills, but some still gets in.

Watch for unusual bruising, nosebleeds, bleeding gums, black or bloody stools, or a sudden bad headache. Keep using both as prescribed. Your pharmacist and doctor can keep a closer eye on you and help keep you safe.

Effect: Increased bleeding risk, including intracranial , reported within 30 days of starting combined and therapy. Severity: major. Evidence: established. Onset: unspecified.

Mechanism: Not established. It is likely , with impairment of hemostasis (NSAID COX-1 of thromboxane plus possible TCA effects on platelet uptake). It is not a interaction. Systemic diclofenac exposure from the transdermal patch is low compared with oral dosing, but it is not negligible.

  • Use caution with .
  • Monitor for bleeding: bleeding, bruising, hematuria, and neurologic signs of ICH, especially during the first 30 days.
  • Consider additional risk factors such as , antiplatelets, older age, and history of GI bleeding.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Diclofenac Transdermal Patch and Opipramol Interact

The likely mechanism

Unknown

“Unknown” here means the studies and labels behind this record do not say how the interaction happens. It does not mean the interaction is unlikely.

When two medicines can each cause the same effect, here bleeding, taking them together can add to it. That is often the reason for an interaction like this one, though the sources do not confirm it for this pair.

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Diclofenac Transdermal Patch and Opipramol Interaction

Your care team can manage this combination safely by watching you more closely for signs of bleeding, especially during the first month you use both together.

  • Keep using both medicines exactly as prescribed. Do not stop either one on your own.
  • Tell your pharmacist or doctor if you notice unusual bruising, bleeding gums, nosebleeds, blood in your urine, or black or bloody stools.
  • Get medical help right away if you have a sudden severe headache, confusion, weakness, or trouble speaking.
  • Let your team know about any , aspirin, or other pain relievers you take.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Diclofenac Transdermal Patch or Opipramol need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs: nationwide propensity score matched study

    When were taken together with antidepressants (including , , -norepinephrine reuptake , and ), the risk of intracranial within 30 days of combined use was higher than with antidepressant use alone. The elevated risk did not differ significantly among the antidepressant drug classes; however, male patients had a greater associated risk than female patients.1

Diclofenac Transdermal Patch and Opipramol: Common Questions

How serious is the Diclofenac Transdermal Patch and Opipramol interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Diclofenac Transdermal Patch and Opipramol interaction managed?

Your care team can manage this combination safely by watching you more closely for signs of bleeding, especially during the first month you use both together. Keep using both medicines exactly as prescribed. Do not stop either one on your own. Tell your pharmacist or doctor if you notice unusual bruising, bleeding gums, nosebleeds, blood in your urine, or black or bloody stools. Get medical help r… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "established". Well documented — supported by controlled studies or strong clinical data.

Ask About the Diclofenac Transdermal Patch and Opipramol Interaction

Ask in your own words about taking Diclofenac Transdermal Patch and Opipramol together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Shin JY, Park MJ, Lee SH, et al: Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs: nationwide propensity score matched study. BMJ 2015; 351:h3517. PubMed
Was this write-up helpful?

Other Serious Interactions of Diclofenac Transdermal Patch and Opipramol

Also serious with Opipramol

Also serious with Diclofenac Transdermal Patch

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data. This interaction.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.